ASP Isotopes Inc. (ASPI) experienced a wild day on the stock market Tuesday, with its shares initially soaring more than 35% in pre-market trading on news of a deal with TerraPower, a company backed by Bill Gates, to build a facility for producing High Assay Low-Enriched Uranium (HALEU).
The agreement, announced early Tuesday, saw ASPI sign a term sheet with TerraPower to construct a uranium enrichment facility capable of producing HALEU for TerraPower's planned $4 billion Natrium nuclear reactor project in Wyoming. Under the deal, TerraPower will provide funding for the facility's construction, and the companies plan to sign a long-term supply agreement for all HALEU produced over a 10-year period.
However, the euphoria was short-lived as ASPI's stock plunged 5.51% in after-hours trading, raising concerns among investors. The lack of financial details disclosed in the deal announcement, potential proliferation risks associated with HALEU production, and uncertainty surrounding the facility's location, which is expected to be in South Africa according to reports, may have contributed to the sell-off.
Comments